Explore

Trendline Trendline
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026

Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Trendline Trendline
Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences

Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences

Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences
Trendline Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments

Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Trendline Trendline
Vanda Pharmaceuticals to Engage in Key May 2026 Investor Conferences

Vanda Pharmaceuticals to Engage in Key May 2026 Investor Conferences

Vanda Pharmaceuticals to Engage in Key May 2026 Investor Conferences
Trendline Trendline
Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus

Travere Therapeutics to Present at Major Investor Conferences, Highlighting Rare Disease Focus
Trendline Trendline
Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences Across the U.S.

Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences Across the U.S.

Vanda Pharmaceuticals to Participate in May 2026 Investor Conferences Across the U.S.
Trendline Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Trendline Trendline
Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference

Vir Biotechnology to Present at Bank of America Healthcare Conference
Trendline Trendline
Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.

Stevanato Group Announces Participation in Three Major Investor Conferences in the U.S.
Trendline Trendline
Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast

Curis to Announce Q1 2026 Financial Results and Host Webcast
Trendline Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Stock Repurchase Program

Exelixis Reports Q1 2026 Financial Results and Announces New Stock Repurchase Program

Exelixis Reports Q1 2026 Financial Results and Announces New Stock Repurchase Program